Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk

Breast Cancer Research and Treatment

Volumn 97, Issue 1, 2006, Pages 67-72

  Langsenlehner, Uwe ^a   Renner, Wilfried ^a   Yazdani Biuki, Babak ^a   Eder, Tanja ^a   Wascher, Thomas C ^a   Paulweber, Bernhard ^b   Clar, Heimo ^a   Hofmann, Günter ^a   Samonigg, Hellmut ^a   Krippl, Peter ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF SALZBURG   (Austria)

Author keywords

Breast cancer; Epidemiology; Genetics; Glykoprotein; Integrin

Indexed keywords

ALPHA2 INTEGRIN; ALPHA2BBETA3 INTEGRIN; BETA3 INTEGRIN; CELL SURFACE RECEPTOR; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2; VITRONECTIN RECEPTOR;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GENETICS; CANCER GRADING; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CAUCASIAN; CELL ADHESION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR DENSITY; REGRESSION ANALYSIS; SIGNAL TRANSDUCTION;

BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTEGRIN ALPHA2; INTEGRIN BETA3; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS; SURVIVAL RATE;

EID: 33646746155     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-9089-4     Document Type: Article

References (22)

1. Parise LV, Lee J, Juliano RL: New aspects of integrin signaling in cancer. Semin Cancer Biol 10: 407-414, 2000
2. Nierodzik ML, Klepfish A, Kaspatkin S: Role of the platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand Factor on tumor adhesion in vitro and metastasis in vivo. Thromb Haemost 74: 282-290, 1995
3. Gui GPH, Puddefoot JR, Vinson GP, Wells CA, Carpenter R: Altered cell-matrix contact: a prerequisite for breast cancer metastasis? Br J Cancer 75: 623-633, 1997
4. Felding-Habermann B, O'Toole TE, Smith JW, Fransvea E, Ruggeri ZM, Ginsberg MH, et al.: Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci USA 98: 1853-1858, 2001
5. Hood JD, Cheresh DA: Role of integrins in cell invasion and migration. Nat Rev Cancer 2: 91-100, 2002
6. Varner JA, Cheresh DA: Tumor angiogenesis and the role of vascular cell integrin alphavbeta3. Important Adv Oncol 69-87, 1996
7. Kritzik M, Savage B, Nugent DJ, Santoso S, Ruggeri ZM, Kunicki TJ: Nucleotide polymorphisms in the α2 gene define multiple alleles that are associated with differences in platelet α2β1 density. Blood 92: 2382-2388, 1998
8. Corral J, Rivera J, González-Conejero R, Vicente V: The platelet GP Ia receptor density associates with the genetically linked 807 C/T and HPA-5 polymorphisms. Transfusion 39: 372-378, 1999
9. Bennett JS, Catella-Lawson F, Rut AR, Vilaire G, Qi W, Kapoor SC, Murphy S, FitzGerald GA: Effect of the Pl(A2) alloantigen on the function of beta(3)-integrins in platelets. Blood 97: 3093-3099, 2001
10. Vijayan KV, Liu Y, Dong JF, Bray PF: Enhanced activation of mitogenactivated protein kinase and myosin light chain kinase by the Pro33 polymorphism of integrin beta 3. J Biol Chem 278: 3860-3867, 2003
11. Feng D, Lindpaintner K, Larson MG, Rao VS, O'Donnell CJ, Lipinska I, Schmitz C, Sutherland PA, Silbershatz H, D'Agostino RB, Muller JE, Myers RH, Levy D, Tofler GH: Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 19: 1142-1147, 1999
12. Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Haas J, Samonigg H: A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 106: 468-471, 2003
13. Langsenlehner U, Krippl P, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Weitzer W, Samonigg H: The common 677C > T gene polymorphism of methylenetetrahydrofolate reductase gene is not associated with breast cancer risk. Breast Cancer Res Treat 81: 169-172, 2003
14. Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Köppel H, Samonigg H: The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer. Clin Cancer Res 10: 3518-3520, 2004
15. Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Weitzer W, Leithner A, Samonigg H: The 870G > A polymorphism of the Cyclin D1 gene is not associated with breast cancer. Breast Cancer Res Treat 82: 165-168, 2003
16. Esterbauer H, Schneitler C, Oberkofler H, Ebenbichler C, Paulweber B, Sandhofer F, Ladurner G, Hell E, Strosberg AD, Patsch JR, Krempler F, Patsch W: A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet 28: 178-183, 2001
17. Stephens M, Smith NJ, Donnelly P: A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68: 978-989, 2001
18. Zutter MM, Mazoujian G, Santoro SA: Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast. Am J Pathol 137: 863-870, 1990
19. Zutter MM, Santoro SA, Staatz WD, Tsung YL: Re-expression of the alpha 2 beta 1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc Natl Acad Sci USA 92: 7411-7415, 1995
20. Ayala F, Corral J, Gonzalez-Conejero R, Sanchez I, Moraleda JM, Vicente V: Genetic polymorphisms of platelet adhesive molecules: association with breast cancer risk and clinical presentation. Breast Cancer Res Treat 80: 145-154, 2003
21. Wang-Gohrke S, Chang-Claude J: Integrin beta3 Leu33Pro polymorphism and breast cancer risk: a population-based case-control study in Germany. Breast Cancer Res Treat 88: 231-237, 2004
22. Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG: Integrin beta3 Leu33Pro homozygosity and risk of cancer. J Natl Cancer Inst 95: 1150-1157, 2003